FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Germany

Biotech investors in Germany

Updated 16 Nov 2026

Reset

Venture funds

4 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 HTGF (High-Tech Gruenderfonds)
HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate.
Bonn, Germany
Biotech, Health care Seed, Early stage venture, Late stage venture 28% 5
2 BlueYard Capital
BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio.
Berlin, Germany
Fintech, Biotech Seed, Early stage venture 41% 3
3 Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix.
Ingelheim Am Rhein, Germany
Biotech, Health care Seed, Early stage venture 47% 3
4 Nucleus Capital
Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia.
Berlin, Germany
Biotech, Health care Seed, Early stage venture 32% 2

Table 1. Biotech investors in Germany: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Germany
One-time CSV
  • 60 firms, 59 with a website
  • 44 firm email addresses
  • 39 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-germany.csv60 rows × 15 columns
InvestorTypeLocationEmailPhone
HTGF (High-Tech Gruenderfonds)Venture capital firmBonn, Germany•••@htgf.de+49 22•••
KfWGovernment investment officeFrankfurt, Germany•••@kfw.de49 69 •••
Bayern KapitalVenture capital firmLandshut, Germany•••@bayernkapital.de+49871•••
Wellington PartnersVenture capital firmMunich, Germany•••@wellington-partners.com+44 20•••
NRW.BANKGovernment investment officeDüsseldorf, Germany•••@nrwbank.de+32 2 •••
MIG CapitalVenture capital firmMunich, Germany•••@mig.ag
German Federal Ministry of Research, Technology and SpaceGovernment investment officeBonn, Germany•••@bmftr.bund.de+49 (0•••
Fraunhofer VentureVenture capital firmMunich, Germany•••@fraunhoferventure.de+49 89•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

60
Investors
44
With email
39
With phone
39
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Germany

30 of 60, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany Biotech, Health care Rabot Energy, CereGate, syte 17 1,026 290 136 •••@htgf.de +49 22••• In the CSV
2 KfW Government investment office, Investment bank Frankfurt, Germany Biotech, Health care CryoTherapeutics, Vectoflow, HelloDuty 198 29 56 •••@kfw.de 49 69 ••• In the CSV
3 Bayern Kapital Venture capital firm Landshut, Germany Health care, Artificial intelligence mbiomics, SPiNE, Driveblocks 4 294 41 41 •••@bayernkapital.de +49871••• In the CSV
4 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany Biotech, Health care smartbax, xCures, Tacalyx 4 99 47 12 +49 61•••
5 Wellington Partners Venture capital firm Munich, Germany Health care, Biotech nyra health 1 252 80 65 •••@wellington-partners.com +44 20••• In the CSV
6 NRW.BANK Government investment office, Investment bank Düsseldorf, Germany Artificial intelligence, Biotech Lumoview Building Analytics, Elixion Medical, Alteva 126 28 17 •••@nrwbank.de +32 2 ••• In the CSV
7 MIG Capital Venture capital firm Munich, Germany Biotech, Health care NavVis, mbiomics 2 95 43 15 •••@mig.ag In the CSV
8 Leaps by Bayer Corporate venture arm Leverkusen, Germany Health care, Biotech 9amHealth, CORXEL Pharmaceuticals 2 113 45 13 In the CSV
9 BlueYard Capital Venture capital firm Berlin, Germany Fintech, Biotech Zafrens, Castelion, Transcripta Bio 7 102 42 4 +49 61••• In the CSV
10 German Federal Ministry of Research, Technology and Space Government investment office Bonn, Germany Biotech, Health care eClear, NVision Quantum Technologies 2 62 39 13 •••@bmftr.bund.de +49 (0••• In the CSV
11 Fraunhofer Venture Venture capital firm Munich, Germany Biotech, Health care Cellbox Solutions 1 40 6 5 •••@fraunhoferventure.de +49 89••• In the CSV
12 Possible Ventures Venture capital firm Munich, Germany Hardware, Artificial intelligence Antaris, Arlula, InSpacePropulsion Technologies 4 152 9 9 In the CSV
13 IFB Innovationsstarter Venture capital firm Hamburg, Germany Health care, Biotech recalm, apoQlar, SupplyET 88 35 6 +49 40••• In the CSV
14 LBBW VC Corporate venture arm Stuttgart, Germany Biotech, Health care Exciva 1 47 14 7 +49 71••• In the CSV
15 Nucleus Capital Venture capital firm Berlin, Germany Biotech, Health care Apoha, Biomia 2 44 14 2 In the CSV
16 Amino Collective Venture capital firm Berlin, Germany Health care, Biotech Tandem Health, Rivia, Biomia 3 42 2 2 •••@aminocollective.com In the CSV
17 EMBL Ventures Venture capital firm Heidelberg, Germany Biotech, Health care Luxendo, Allecra Therapeutics, ImevaX 20 5 6 •••@embl-ventures.com +49 (6••• In the CSV
18 b.value AG Venture capital firm Dortmund, Germany Biotech, Health care Cellbricks Therapeutics 1 13 3 0 •••@b-value.de +49 (0••• In the CSV
19 Earlybird Venture Capital Venture capital firm Berlin, Germany Artificial intelligence, Fintech finmid, ColibrITD, Quantum Diamonds 7 348 143 59 +49 30••• In the CSV
20 bmp Ventures Venture capital firm Berlin, Germany Health care, Biotech RAYDIAX 1 123 49 20 •••@bmp.com + 49- ••• In the CSV
21 BASF Venture Capital Corporate venture arm Ludwigshafen, Germany Biotech, Artificial intelligence Computomics 1 88 35 18 973 24••• In the CSV
22 Brandenburg Kapital Government investment office, Venture capital firm Potsdam, Germany Biotech, Energy Kupando 1 73 31 7 •••@ilb.de +49 33••• In the CSV
23 Think.Health Venture capital firm Fürstenfeldbruck, Germany Health care, Biotech Sphingotec GmbH, Myo, Vara 33 12 4 •••@think-health.de
24 Picus Capital Venture capital firm Munich, Germany Fintech, Artificial intelligence Reflex, Baselayer, FINN 8 337 68 18 •••@picuscap.com +49 89••• In the CSV
25 IBB Ventures Venture capital firm Berlin, Germany Artificial intelligence, Health care Ascléa, ARC Intelligence, Qdrant 3 265 49 43 •••@ibbventures.de 030 - ••• In the CSV
26 APX Venture capital firm Berlin, Germany Artificial intelligence, Fintech VisioLab 1 182 50 10 •••@apx.vc
27 TGFS - Technologiegründerfonds Sachsen Venture capital firm Leipzig, Germany Artificial intelligence, Hardware Prodlane, BirdsView, Peeriot 4 160 36 11 •••@tgfs.de +49341••• In the CSV
28 UVC Partners Venture capital firm Garching, Germany Artificial intelligence, Biotech Reel Energy, Synera, Rencore 3 129 50 13 •••@uvcpartners.com In the CSV
29 eCAPITAL ENTREPRENEURIAL PARTNERS Venture capital firm Münster, Germany Biotech, Cybersecurity Ferroelectric Memory Company, Papershift, envelio 122 84 25 •••@ecapital.vc +49 (0••• In the CSV
30 coparion Startup accelerator Cologne, Germany Biotech, Hardware Tacalyx 1 96 5 15 •••@coparion.vc +49 30••• In the CSV

Table 2. Biotech investors in Germany: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 60.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 HTGF (High-Tech Gruenderfonds) Bonn, Germany 17 257 Rabot Energy, CereGate, syte
2 Picus Capital Munich, Germany 8 69 Reflex, Baselayer, FINN
3 BlueYard Capital Berlin, Germany 7 25 Zafrens, Castelion, Transcripta Bio
4 Earlybird Venture Capital Berlin, Germany 7 72 finmid, ColibrITD, Quantum Diamonds
5 Cherry Ventures Berlin, Germany 7 58 Moss, Stenon, bunch
6 Leblon Capital Munich, Germany 5 38 Mural, Rivio, Taktile
7 HV Capital Munich, Germany 5 72 Rabot Energy, FINN, NEURA Robotics
8 TGFS - Technologiegründerfonds Sachsen Leipzig, Germany 4 22 Prodlane, BirdsView, Peeriot
9 Boehringer Ingelheim Venture Fund Ingelheim Am Rhein, Germany 4 14 smartbax, xCures, Tacalyx
10 Bayern Kapital Landshut, Germany 4 69 mbiomics, SPiNE, Driveblocks
11 Possible Ventures Munich, Germany 4 36 Antaris, Arlula, InSpacePropulsion Technologies
12 SquareOne Venture Capital Berlin, Germany 3 22 Procuros, Zuriq, Graph Therapeutics
13 Amino Collective Berlin, Germany 3 11 Tandem Health, Rivia, Biomia
14 IBB Ventures Berlin, Germany 3 62 Ascléa, ARC Intelligence, Qdrant
15 UVC Partners Garching, Germany 3 26 Reel Energy, Synera, Rencore

Table 3. Biotech investors in Germany: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego, United States Series A $6.0M 2026-11-03 $35.0M BlueYard Capital 11 to 50 2022
Reflex Reflex is an open-source Python framework for building and deploying web applications. Software San Francisco, United States Series A $14.0M 2026-10-29 $19.5M Picus Capital 11 to 50 2023
Mural Mural offers a financial platform for cross-border payments, fund transfers, and digital asset transactions. Fintech New York, United States Series A $15.0M 2026-10-20 $20.6M Leblon Capital 11 to 50 2022
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne, Germany Series A $1.7M 2026-10-20 $15.3M Fraunhofer Venture 11 to 50 2017
Rabot Energy Rabot Energy supplies green electricity with flexible and smart tariffs for homes and electric vehicles. Energy Hamburg, Germany Series B $56.1M 2026-10-14 $79.7M HV Capital, HTGF (High-Tech Gruenderfonds) 101 to 250 2021
finmid finmid provides embedded lending infrastructure that powers platform growth. Fintech Berlin, Germany Series A $19.1M 2026-10-06 $58.0M Earlybird Venture Capital 11 to 50 2021
Procuros Procuros is a fintech company that automates manual B2B transactions into transparent flows. Fintech Hamburg, Germany Series A $22.3M 2026-10-05 $32.5M SquareOne Venture Capital 11 to 50 2021
Baselayer Baselayer automates risk assessment and fraud detection for financial and government institutions. Artificial intelligence New York, United States Series A $35.0M 2026-09-22 $82.0M Picus Capital 51 to 100 2024
syte Syte uses AI to analyze property data and help real estate buyers judge development potential and economic viability. Artificial intelligence Münster, Germany Series A $10.3M 2026-09-17 $19.2M HTGF (High-Tech Gruenderfonds) 11 to 50 2021
Tandem Health Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. Artificial intelligence Stockholm, Sweden Series B $100.0M 2026-09-14 $159.7M Amino Collective 101 to 250 2023

Table 4. Biotech investors in Germany: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 832 68%
Artificial intelligence 260 21%
Health care 238 19%
Biotech 208 17%
Hardware 163 13%
Fintech 163 13%
Commerce 110 9%
Education 40 3%
Energy 37 3%
Cybersecurity 32 3%

Table 5. Biotech investors in Germany: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in Germany by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Munich 14 23%
Berlin 13 22%
Stuttgart 3 5%
Bonn 2 3%
Frankfurt 2 3%
Hamburg 2 3%
Heidelberg 2 3%
Potsdam 2 3%
Cologne 2 3%
Landshut 1 2%
Ingelheim Am Rhein 1 2%
Düsseldorf 1 2%

Table 7. Biotech investors in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 3 5%
2010s 19 34%
2000s 19 34%
1990s 9 16%
1980s 1 2%
1970s 2 4%

Table 8. Biotech investors in Germany by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Germany are on the list?
60, in the file dated 16 November 2026. 39 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
44 of the 60 carry an email address in the download and 39 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 60 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 60 rows, 44 firm email addresses and 39 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 35 of the 44 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Germany: 60 rows, CSV, $29 one-time.

At once: the CSV with 60 rows, 44 firm email addresses and 39 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 35 of the 44 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in Germany

Other portfolio sectors in Germany

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 60 biotech investors in Germany, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/germany/